These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 1362653)

  • 1. Insights into the mechanisms of action of the MAO inhibitors phenelzine and tranylcypromine: a review.
    Baker GB; Coutts RT; McKenna KF; Sherry-McKenna RL
    J Psychiatry Neurosci; 1992 Nov; 17(5):206-14. PubMed ID: 1362653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of five clinically used inhibitors of monoamine oxidase using the fluorescence microscopy method.
    Bartonícek V
    Med Pharmacol Exp Int J Exp Med; 1967; 16(2):142-6. PubMed ID: 5298397
    [No Abstract]   [Full Text] [Related]  

  • 3. [Various effects of monoamine oxidase inhibitors under conditions of complete monoamine oxidase inhibition on the serotonin, dopamine and noradrenaline levels in the rat brain].
    Matthies H; Popov N
    Acta Biol Med Ger; 1966; 17(4):488-97. PubMed ID: 5983631
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics of monoamine oxidase inhibitors.
    Mallinger AG; Smith E
    Psychopharmacol Bull; 1991; 27(4):493-502. PubMed ID: 1813896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-Methoxytranylcypromine, a monoamine oxidase inhibitor: effects on biogenic amines in rat brain following chronic administration.
    Sherry-McKenna RL; Baker GB; Mousseau DD; Coutts RT; Dewhurst WG
    Biol Psychiatry; 1992 May; 31(9):881-8. PubMed ID: 1353376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychotropic drugs (2). Interaction between monoamine oxidase (MAO) inhibitors and other substances.
    Sjöqvist F
    Proc R Soc Med; 1965 Nov; 58(11 Part 2):967-78. PubMed ID: 4952963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The opposite effect of isotype-selective monoamine oxidase inhibitors on adipogenesis in human bone marrow mesenchymal stem cells.
    Byun Y; Park J; Hong SH; Han MH; Park S; Jung HI; Noh M
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3273-6. PubMed ID: 23611731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of dihydroxyphenylalanine on the serotonin content of rat brain following pretreatment with monoamine oxidase inhibitors].
    Popov N; Matthies H
    Acta Biol Med Ger; 1966; 17(5):637-43. PubMed ID: 5991588
    [No Abstract]   [Full Text] [Related]  

  • 9. Reversibility of MAO inhibition.
    Baxter LR
    J Clin Psychiatry; 1984 May; 45(5):234. PubMed ID: 6725215
    [No Abstract]   [Full Text] [Related]  

  • 10. Regional concentrations of cerebral amines: effects of tranylcypromine and phenelzine.
    McKim RH; Calverly DG; Dewhurst WG; Baker GB
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):783-6. PubMed ID: 6141618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The modification of the effect of phenelzine, phenylpropylhydrazine and aminooxyacetic acid on the content of gamma-aminobutyric acid in the rat brain by monoamine oxidase inhibitors].
    Matthies H; Popov N
    Acta Biol Med Ger; 1968; 20(3):371-8. PubMed ID: 5725428
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of the pharmacological and biochemical properties of substrate-selective monoamine oxidase inhibitors.
    Christmas AJ; Coulson CJ; Maxwell DR; Riddell D
    Br J Pharmacol; 1972 Jul; 45(3):490-503. PubMed ID: 5072232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoamine oxidase inhibitors phenelzine and brofaromine increase plasma serotonin and decrease 5-hydroxyindoleacetic acid in patients with major depression: relationship to clinical improvement.
    Celada P; Pérez J; Alvarez E; Artigas F
    J Clin Psychopharmacol; 1992 Oct; 12(5):309-15. PubMed ID: 1282522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of various monoamine oxidase inhibitors on the structure of the sleep-wakefulness cycle of the cat].
    Oniani TN; Akhvlediani GR
    Fiziol Zh SSSR Im I M Sechenova; 1987 Mar; 73(3):332-7. PubMed ID: 3582693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of some MAO inhibitors and neuroleptics on enzymes concerned in GABA metabolism.
    Simánĕ Z; Kraus P
    Act Nerv Super (Praha); 1968 Oct; 10(3):331. PubMed ID: 4387433
    [No Abstract]   [Full Text] [Related]  

  • 16. Clonidine potentiates the effects of tranylcypromine, phenelzine and two analogues in the forced swimming test in mice.
    Bourin M; Hascoët M; Colombel MC; Coutts RT; Baker GB
    J Psychiatry Neurosci; 2002 May; 27(3):178-85. PubMed ID: 12066447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between the pharmacological and biochemical properties of a monoamine oxidase inhibitor preferentially affecting 5-hydroxytryptamine oxidation.
    Christmas AJ; Hall DW; Hayward A; Maxwell DR
    Br J Pharmacol; 1970 May; 39(1):207P-208P. PubMed ID: 5420104
    [No Abstract]   [Full Text] [Related]  

  • 18. Neurochemical effects of the monoamine oxidase inhibitor phenelzine on brain GABA and alanine: A comparison with vigabatrin.
    Todd KG; Baker GB
    J Pharm Pharm Sci; 2008 May; 11(2):14s-21s. PubMed ID: 19203467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorinated phenylcyclopropylamines. Part 3: Inhibition of monoamine oxidase A and B.
    Yoshida S; Rosen TC; Meyer OG; Sloan MJ; Ye S; Haufe G; Kirk KL
    Bioorg Med Chem; 2004 May; 12(10):2645-52. PubMed ID: 15110846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of inhibitors of monoamine oxidase on various enzymes and on the storage of monoamines.
    GEY KF; PLETSCHER A; BURKARD W
    Ann N Y Acad Sci; 1963 Jul; 107():1147-51. PubMed ID: 13947443
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.